Bertino
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies 4
-
- Cancer-related Molecular Pathways 3
-
- Lung Cancer Treatments and Mutations 8
-
- Synthesis and Characterization of Heterocyclic Compounds 2
-
- Radiopharmaceutical Chemistry and Applications 2
-
- Cancer Research and Treatments 2
-
- Chronic Lymphocytic Leukemia Research 2
-
- Cancer, Hypoxia, and Metabolism 2
- Journals
- Journal of Investigative Dermatology (1 paper)世界胃肠病学杂志：英文版 (1 paper)世界胃肠病学杂志：英文版（电子版） (1 paper)
- Partner nations
- United StatesItaly
In The Last Decade
Bertino
27 papers receiving 466 citations
Peers
Comparison fields: 5 of 80
- Otorhinolaryngology 48
- Oncology 190
- Hematology 69
- Public Health, Environmental and Occupational Health 130
- Pathology and Forensic Medicine 70
Countries citing papers authored by Bertino
This map shows the geographic impact of Bertino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertino more than expected).
Fields of papers citing papers by Bertino
This network shows the impact of papers produced by Bertino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertino. The network helps show where Bertino may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bertino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Gut microbiota in alcoholic liver disease: Pathogenetic role and therapeutic perspectives | 2014 | 1 |
| 2 | L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin | 2011 | 1 |
| 3 | Exposing Copy-Paste-Blur Forgeries Based on Color Coherence | 2009 | 1 |
| 4 | Pretreatment of endometrial carcinoma cell lines with butyrate results in upregulation of Bax and correlates with potentiation of radiation induced cell kill. | 2001 | 8 |
| 5 | Current understanding of methotrexate pharmacology and efficacy in acute leukemias. Use of newer antifolates in clinical trials. | 2001 | 69 |
| 6 | Transfection of wild-type but not mutant p53 induces early monocytic differentiation in HL60 cells and increases their sensitivity to stress. | 1995 | 42 |
| 7 | Transfection of a nonactive site mutant murine DHFR cDNA (the tryptophan 15 mutant) into Chinese hamster ovary and mouse marrow progenitor cells imparts MTX resistance in vitro. | 1994 | 4 |
| 8 | Detection of Monoclonal Lymphoid Subpopulations in Clinical Specimens by Pcr and Conformational Polymorphisms of Crna Molecules | 1992 | 4 |
| 9 | Enzymes of the thymidylate cycle as targets for chemotherapeutic agents: mechanisms of resistance. | 1992 | 6 |
| 10 | Sequential methotrexate and 5-fluorouracil: mechanisms of synergy. | 1983 | 36 |
| 11 | Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma. | 1982 | 18 |
| 12 | Possible hazards of working with cytotoxic agents: a review of the literature. | 1981 | 8 |
| 13 | Inhibition of two human tumor cell lines by antimetabolites of coenzyme Q10. | 1978 | 10 |
| 14 | Natural resistance to methotrexate in human acute nonlymphocytic leukemia. | 1977 | 16 |
| 15 | Clinical and pharmacological evaluation of triazinate in humans. | 1976 | 20 |
| 16 | Improved therapeutic index of methotrexate with "leucovorin rescue". | 1973 | 123 |
| 17 | The Yale combination chemotherapy program for advanced Hodgkin's disease. A preliminary report. | 1970 | 2 |
| 18 | Effectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck. | 1968 | 48 |
| 19 | Symposium on immunosuppressive drugs. Folate antagonists: some biochemical and pharmacological considerations. | 1967 | 6 |
| 20 | TECHNIQUES FOR STUDY OF RESISTANCE TO FOLIC ACID ANTAGONISTS. | 1964 | 52 |
About Bertino
Bertino is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 520 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Head and Neck Cancer Studies (4 papers), Cancer-related Molecular Pathways (3 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Cancer Research and Treatments (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Otorhinolaryngology (48 citations), Oncology (190 citations) and Hematology (69 citations). Bertino has collaborated with scholars based in United States and Italy. Frequent co-authors include Mitchell Ms, Papac Rj, Martin Levitt, Enrico Mini, Thomas Ed, Kaplan, Rose J. Papac, Colin Paul Spears, P. V. Danenberg and H.J. Lenz. Their work appears in journals such as Journal of Investigative Dermatology, 世界胃肠病学杂志：英文版, 世界胃肠病学杂志：英文版（电子版）, 电子学报：英文版 and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.